We are a precision oncology company pioneering the development of cancer therapies guided by functional genomics. We develop treatments for patients with genetically defined cancers, whose current treatment options are limited. A UNIQUE APPROACH To address the unmet needs of a diverse patient population, we’ve developed unique AI-supported drug discovery methods that accurately identify oncogenic […]
Total raised: $6M
Investors 1
| Date | Name | Website |
| - | Helsinn In... | helsinninv... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 30.04.2018 | - | $6M | - | finsmes.co... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 01.05.2018 | Term Sheet... | A TALE OF TWO COMEBACKS Good ... | - | - | fortune.co... |
| 30.04.2018 | NovellusDx... | NovellusDx, a Jerusalem, Israe... | Israel | - | finsmes.co... |